EcoDrugPlus

Motilin Receptor

Ensembl ID : ENSSMAG00000002647
Gene Symbol: MLNR
3 Cross references
174 Possible Orthologues:

Muscarinic Acetylcholine Receptor M1

Ensembl ID : ENSSMAG00000019748
Gene Symbol: LOC118288090
2 Cross references
186 Possible Orthologues:

Muscarinic Acetylcholine Receptor M2-Like

Ensembl ID : ENSSMAG00000006259
Gene Symbol: LOC118315894
2 Cross references
185 Possible Orthologues:

Natriuretic Peptide Receptor 1a

Ensembl ID : ENSSMAG00000014890
Gene Symbol: NPR1A
3 Cross references
190 Possible Orthologues:

Natriuretic Peptide Receptor 3

Ensembl ID : ENSSMAG00000000302
Gene Symbol: NPR3
3 Cross references
211 Possible Orthologues:

Neuronal Acetylcholine Receptor Subunit Alpha-7-Like

Ensembl ID : ENSSMAG00000010613
Gene Symbol: LOC118302088
2 Cross references
205 Possible Orthologues:

Neuropeptide Y Receptor Y2

Ensembl ID : ENSSMAG00000001763
Gene Symbol: NPY2R
2 Cross references
184 Possible Orthologues:

Neuropeptide Y Receptor Y2, Like

Ensembl ID : ENSSMAG00000017038
Gene Symbol: NPY2RL
1 Cross references
176 Possible Orthologues:

Neurotensin Receptor 1 (High Affinity)

Ensembl ID : ENSSMAG00000030907
Gene Symbol: NTSR1
2 Cross references
203 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSSMAG00000019401
Gene Symbol: NTRK2
1 Cross references
207 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSSMAG00000010859
Gene Symbol: NTRK3
3 Cross references
192 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 1

Ensembl ID : ENSSMAG00000013025
Gene Symbol: NTRK1
3 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).